Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,280 active trials259 approved drugs3,813 evidence items
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,351 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00817258 | Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal Carcinoma | unknown | Phase 2 | 37 | Fudan UniversityOTHER | 1 | Jan 6, 2009 | clinicaltrials |
| NCT00816816 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma | unknown | Phase 2 | 64 | Fudan UniversityOTHER | 1 | Jan 5, 2009 | clinicaltrials |
| NCT00816855 |
| Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma |
| unknown |
| Phase 2 |
| 52 |
| Fudan UniversityOTHER |
| 1 |
| Jan 5, 2009 |
| clinicaltrials |
| NCT00805896 | Songyou Granule and Transarterial Chemoembolization for Hepatocellular Carcinoma | unknown | Phase 2 | 260 | Fudan UniversityOTHER | 1 | Dec 31, 2008 | clinicaltrials |
| NCT00815568 | Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI) | unknown | Phase 2 | 114 | Samsung Medical CenterOTHER | 1 | Dec 30, 2008 | clinicaltrials |
| NCT00808379 | Concurrent Chemo-Radiotherapy Versus Radiotherapy With Boost in Locally Advanced Unresectable Rectal Cancers | unknown | Phase 2 | 90 | Tata Memorial HospitalOTHER_GOV | 1 | Dec 15, 2008 | clinicaltrials |
| NCT00807261 | Weekly Docetaxel and Fixed-Dose Rate Gemcitabine Combination Chemotherapy | unknown | Phase 2 | 30 | Asan Medical CenterOTHER | 0 | Dec 12, 2008 | clinicaltrials |
| NCT00807196 | Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma | unknown | Phase 1 / Phase 2 | 20 | Maisonneuve-Rosemont HospitalOTHER | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00804947 | Autologous Stem Cell Transplant (ASCT) With Intravenous Busulfan and Melphalan as Conditioning Regimen | unknown | Phase 2 | 50 | Fundacion Para La Investigacion Hospital La FeOTHER | 1 | Dec 9, 2008 | clinicaltrials |
| NCT00800943 | Study of Subcutaneous Campath-1H in Patients With B-Cell CLL and Residual Disease After Chemotherapy(CRC005) | unknown | Phase 2 | 31 | Chronic Lymphocytic Leukemia Research ConsortiumNETWORK | 1 | Dec 3, 2008 | clinicaltrials |
| NCT00131053 | Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL) | unknown | Phase 2 | 120 | Japan Adult Leukemia Study GroupOTHER | 1 | Nov 14, 2008 | clinicaltrials |
| NCT00524706 | Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | 42 | Shizuoka Cancer CenterOTHER | 1 | Nov 13, 2008 | clinicaltrials |
| NCT00788281 | A Multi-Center Randomised Controlled Study to Evaluate Laparoscopic Versus Open Surgery for Colorectal Cancer | unknown | Phase 2 | 200 | Beijing Friendship HospitalOTHER | 1 | Nov 13, 2008 | clinicaltrials |
| NCT00772694 | Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy(GCT) | unknown | Phase 2 | 20 | Fondation Wygrajmy ZdrowieOTHER | 1 | Oct 24, 2008 | clinicaltrials |
| NCT00779896 | Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study | unknown | Phase 1 / Phase 2 | 15 | McGill UniversityOTHER | 1 | Oct 24, 2008 | clinicaltrials |
| NCT00764972 | Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 36 | McGill UniversityOTHER | 1 | Oct 21, 2008 | clinicaltrials |
| NCT00774332 | A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL | unknown | Phase 2 | 37 | Cooperative Study Group A for HematologyNETWORK | 1 | Oct 17, 2008 | clinicaltrials |
| NCT00559221 | FLAG+Ida With G-CSF Priming for Patients Younger Than 60 Years With Resistant AML | unknown | Phase 2 | 37 | Cooperative Study Group A for HematologyNETWORK | 1 | Oct 15, 2008 | clinicaltrials |
| NCT00772798 | A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer | unknown | Phase 2 | 70 | Herlev HospitalOTHER | 1 | Oct 15, 2008 | clinicaltrials |
| NCT00758381 | Metastatic Advanced Pancreas Sorafenib(MAPS) | unknown | Phase 2 | 114 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Oct 10, 2008 | clinicaltrials |
| NCT00669747 | Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) | unknown | Phase 2 | 45 | Windy Hill Medical, Inc.INDUSTRY | 1 | Oct 2, 2008 | clinicaltrials |
| NCT00715325 | ProtectiScope CS Intended for Diagnostic and Therapeutic Colonoscopy | unknown | Phase 1 / Phase 2 | 200 | Stryker GI Ltd.INDUSTRY | 0 | Sep 18, 2008 | clinicaltrials |
| NCT00752063 | Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma(SECOX) | unknown | Phase 2 | 52 | The University of Hong KongOTHER | 1 | Sep 15, 2008 | clinicaltrials |
| NCT00546130 | Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer(RNCLC) | unknown | Phase 2 | 45 | University of ToyamaOTHER | 1 | Sep 3, 2008 | clinicaltrials |
| NCT00728520 | Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy | unknown | Phase 2 | 40 | Kansas City Veteran Affairs Medical CenterFED | 1 | Aug 6, 2008 | clinicaltrials |
| NCT00727350 | Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma. | unknown | Phase 2 | 44 | Universitair Ziekenhuis BrusselOTHER | 1 | Aug 4, 2008 | clinicaltrials |
| NCT00722930 | Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma(GOTEL-FL1LC) | unknown | Phase 2 | 38 | Grupo Oncológico para el Tratamiento y el Estudio de los LinfomasOTHER | 1 | Jul 28, 2008 | clinicaltrials |
| NCT00717951 | A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer | unknown | Phase 2 | 120 | Academy Military Medical Science, ChinaINDUSTRY | 0 | Jul 25, 2008 | clinicaltrials |
| NCT00003001 | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | 63 | Stony Brook UniversityOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00003326 | Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus | unknown | Phase 2 | 100 | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00003327 | Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer | unknown | Phase 2 | 60 | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00006116 | Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00006118 | Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Jul 24, 2008 | clinicaltrials |
| NCT00006120 | Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Jul 24, 2008 | clinicaltrials |
| NCT00010075 | Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00014547 | BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment | unknown | Phase 2 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00024362 | BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery | unknown | Phase 2 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00024388 | Chemotherapy in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00024401 | DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer | unknown | Phase 2 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00024414 | DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 2 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00039156 | BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma | unknown | Phase 2 | — | TheradexINDUSTRY | 2 | Jul 24, 2008 | clinicaltrials |
| NCT00039169 | BAY 59-8862 in Treating Patients With Advanced Kidney Cancer | unknown | Phase 2 | — | TheradexINDUSTRY | 2 | Jul 24, 2008 | clinicaltrials |
| NCT00075465 | Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00075517 | Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00075543 | Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer | unknown | Phase 1 / Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00075738 | Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00303745 | Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | unknown | Phase 2 | 78 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00415987 | Hematopoietic Stem Cell Transplantation in Myeloma | unknown | Phase 2 / Phase 3 | — | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Jun 20, 2008 | clinicaltrials |
| NCT00702247 | Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi) | unknown | Phase 2 | — | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Jun 20, 2008 | clinicaltrials |
| NCT00159094 | A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer | unknown | Phase 2 | 30 | Hematology Oncology ConsultantsOTHER | 1 | Jun 2, 2008 | clinicaltrials |
Data updated 23 days agoSource updated Jan 6, 2009source: clinicaltrials